Table 1: Showing baseline characteristics of the patient cohort.
|
Parameter |
Number (%) |
|
Age |
|
|
Range |
29
– 85 years |
|
Mean ± S.D |
60.24
± 11.45 |
|
Median (IQR) |
62
(18) |
|
Sex |
|
|
Male |
60
(60%) |
|
Female |
40
(40%) |
|
Ratio |
1:5 |
|
Site |
|
|
Upper |
40
(40%) |
|
Middle |
24
(24%) |
|
Lower |
36
(36%) |
|
Histology |
|
|
Squamous cell carcinoma |
83
(83%) |
|
Adenocarcinoma |
17
(17%) |
|
Grade |
|
|
1 |
26
(26%) |
|
2 |
54
(54%) |
|
3 |
11
(11%) |
|
Unknown |
9
(9%) |
|
Imaging |
|
|
CECT |
59
(59%) |
|
PET-CT |
17
(17%) |
|
Others |
24
(24%) |
|
T status |
|
|
T1-2 |
7
(7%) |
|
T3-4 |
69
(69%) |
|
Unknown |
24
(24%) |
|
N status |
|
|
N0 |
32
(32%) |
|
N+ |
44
(44%) |
|
Unknown |
24
(24%) |
CECT: Contrast Enhanced Computed Tomography; PET-CT: Positron
Emission Tomography.